What does Alexandria Venture Investments invest in?
Alexandria Venture Investments invests most often at Series A and Venture (63% of the rounds on record), in sectors such as Biotechnology and Health Care.
Last cheque observed Aug 2026; 126 cheques on record.
Deploying nowVC firm
13 cheques in the last 12 months
Mostly Series A and Venture: 63% of its rounds
Sole investor in 13 rounds, median $12M
Every round we can evidence, newest first126 appearances
10 rounds
23 rounds
28 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
The investors most often in the same rounds as Alexandria Venture Investments. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Alexandria Venture Investments put money into.
Alexandria Venture Investments invests most often at Series A and Venture (63% of the rounds on record), in sectors such as Biotechnology and Health Care.
126 investments on record, 13 of them in the last 12 months. The most recent was in Aug 2026.
Its most recent investments on record: Khartis Therapeutics (Series B, Aug 2026), Georgiamune (Series B, Aug 2026) and Vedana Therapeutics (Series A, Jun 2026).
The median round it joins is $40M.
Rarely, if at all: none of its 126 investments on record names it as the lead.
Most of the companies it backs are in the United States (92%).
Yes: it is actively investing, with 13 investments in the last 12 months.
Most often ARCH Venture Partners (14 rounds together), Eli Lilly (12 rounds together) and Casdin Capital (10 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it